Zydus Lifesciences Revises Buyback Offer: Price Hiked To ₹1,260 Per Share

Zydus Lifesciences has revised the terms of its ongoing share buyback, increasing the repurchase price to ₹1,260 per equity share from ₹1,150 earlier, while reducing the number of shares it plans to buy back under the offer. The changes were approved by the company’s Buyback Committee at its meeting held on 27 May 2026.

Under the revised proposal, Zydus will now buy back up to 87,30,158 fully paid-up equity shares, down from the previously announced 95,65,217 shares. This represents up to 0.87% of the company’s total paid-up equity share capital, compared with around 0.95% under the earlier structure.

On 27 May 2026, Zydus Lifesciences shares surged 0.63% on the National Stock Exchange.

Buyback Size Unchanged Despite Higher Offer Price

Despite the change in price and quantity, the total buyback size remains unchanged at ₹1,100 crore, meaning the company will deploy the same amount of capital but at a higher per-share payout to participating shareholders. The buyback will continue through the tender offer route under the provisions of the Companies Act, 2013 and SEBI’s Buy-Back of Securities Regulations, 2018.

The revised buyback price of ₹1,260 implies an increase of ₹110 per share, or about 9.6%, over the earlier announced ₹1,150 offer price. It also reflects a premium of roughly 16% over the company’s market closing price earlier this week, making the offer more attractive for eligible investors.

Zydus has retained 29 May 2026 as the record date for determining shareholder eligibility for the buyback. Investors needed to purchase shares before the ex-date to qualify. According to reports, the tendering period is expected to run from 4 June to 10 June 2026.

Strong Q4 Earnings Support Shareholder Return Move

The company’s promoter and promoter group, which hold approximately 74.99% stake in Zydus Lifesciences, are also expected to participate in the buyback. Foreign portfolio investors currently hold around 6.86%, while insurance companies own nearly 6.12%.

Also Read - NSE Signs MoU With Steel Users Federation Of India To Strengthen Steel Derivatives Ecosystem

The buyback revision comes shortly after Zydus reported a strong Q4 FY26 performance. The company posted a 14.6% year-on-year rise in consolidated net profit to ₹1,592.9 crore for the March quarter, while revenue from operations rose to ₹7,587 crore from ₹6,527.9 crore a year ago. The consumer wellness segment delivered especially strong growth, with revenue jumping to ₹1,463.3 crore.

Source:

Mint